Annual reports and work programmes

The European Medicines Agency (EMA) publishes a full work programme and annual report, to provide an overview of the work of the Agency together with the European medicines regulatory network.

EMA publishes its annual reports in May / June following the year in question.

We also publish information on the volume and outcome of centralised procedures for human and veterinary medicines. For further details, see Medicine evaluation figures.

Our work programmes - also called programming documents - reflect our priorities and main focus areas for the corresponding period, as well of those of the European medicines regulatory network. 

The work programmes describe objectives and planned activities. They cover:

• Human medicines evaluation activities - split into pre-authorisation, initial evaluation, post-authorisation, pharmacovigilance and referrals
• Veterinary medicines evaluation activities - with a similar structure to the human medicines
• Horizontal activities - that enable and support the evaluation of human and veterinary medicines, including committee coordination, inspections, partner and stakeholder relationship management, and data management
• Corporate governance and support activities - including finance, human resources and quality management

2025 annual report

EMA's 2025 annual report offers insights into key initiatives and priority areas that guided our work in 2025.

The report highlights progress in bringing innovative, safe and effective medicines to patients. 

It also outlines the most important achievements in evaluating and monitoring human and veterinary medicines. 

The report features key figures and an interactive timeline with milestones from 2025. 

Its interactive timeline enables readers to explore each topic in depth by accessing relevant documents, audio-visual materials and infographics.

The report is available in two formats:

• Digital version: with improved accessibility and interactive features
• PDF version: downloadable, printable format with figures and statistics on EMA's regulatory procedures and activities

Image credit: © European Medicines Agency

2026

Final programming document 2026-28

Adopted Reference Number: EMA/10240/2026

2025

EMA's annual report 2025 is available in two formats:

• Digital version: view online for an interactive timeline of EMA’s main activities in 2025 plus visuals and audio-visual materials exploring topics in depth
• PDF version (below): downloadable, printable format with further figures and statistics on EMA's regulatory procedures and activities

2025 annual report of the European Medicines Agency

Annexes - 2025 annual report of the European Medicines Agency

Annex 10 - 2025 annual report of the European Medicines Agency – CHMP opinions on initial evaluations and extensions of therapeutic indication

European Medicines Agency mid-year report 2025 (January-June 2025)

Reference Number: EMA/283452/2025

Final programming document 2025-27

Adopted Reference Number: EMA/30979/2025

2024

EMA's annual report 2024 is available in two formats:

• Digital version: view online for an interactive timeline of EMA’s main activities in 2024 plus visuals and audio-visual materials exploring topics in depth
• PDF version (below): downloadable, printable format with further figures and statistics on EMA's regulatory procedures and activities

2024 annual report of the European Medicines Agency

Annexes - 2024 annual report of the European Medicines Agency

Annex 10 - 2024 annual report of the European Medicines Agency – CHMP opinions on initial evaluations and extensions of therapeutic indication

Final programming document 2024-2026

Adopted Reference Number: EMA/426707/2023

Annual activity report 2024

Reference Number: EMA/69085/2025

European Medicines Agency mid-year report 2024 (January-June 2024)

Reference Number: EMA/298094/2024

2023

EMA's annual report 2023 is available in two formats:

• Digital version: view online for an interactive timeline of EMA’s main activities in 2023 plus visuals and audio-visual materials exploring topics in depth
• PDF version (below): downloadable, printable format with further figures and statistics on EMA's regulatory procedures and activities

2023 annual report of the European Medicines Agency

Annexes - 2023 annual report of the European Medicines Agency

Annex 10 - 2023 annual report of the European Medicines Agency – CHMP opinions on initial evaluations and extensions of therapeutic indication

Final programming document 2023-2025

Reference Number: EMA/36710/2023

Annual activity report 2023

European Medicines Agency mid-year report 2023 (January-June 2023)

Reference Number: EMA/343593/2023

2022

EMA's annual report 2022 is available in two formats:

• Digital version: view online for an interactive timeline of EMA’s main activities in 2022 plus visuals and audiovisual materials exploring topics in depth
• PDF version (below): downloadable, printable format with further figures and statistics on EMA's regulatory procedures and activities

2022 annual report of the European Medicines Agency

Adopted

Annexes - 2022 annual report of the European Medicines Agency

Annex 10 - 2022 annual report of the European Medicines Agency – CHMP opinions on initial evaluations and extensions of therapeutic indication

Final programming document 2022-2024

Reference Number: EMA/32271/2022

Annual activity report 2022

Reference Number: EMA/137754/2023

European Medicines Agency mid-year report 2022 (January-June 2022)

Reference Number: EMA/697686/2022

2021

EMA's annual report 2021 is available in two formats:

• Digital version: view online for an interactive timeline of EMA’s main activities in 2021 plus visuals and audiovisual materials exploring topics in depth
• PDF version (below): downloadable, printable format with further figures and statistics on EMA's regulatory procedures and activities.

2021 annual report of the European Medicines Agency

Adopted

Annexes - 2021 annual report of the European Medicines Agency

Annex 10 - 2021 annual report of the European Medicines Agency – CHMP opinions on initial evaluations and extensions of therapeutic indication

Final programming document 2021-2023

Reference Number: EMA/53919/2021 Summary:

Final programming document 2021-2023

Annual activity report 2021

Reference Number: EMA/75685/2022

European Medicines Agency mid-year report 2021 (January-June 2021)

Reference Number: EMA/352298/2021

2020

EMA's annual report 2020 is available in two formats:

• Digital version: view online for an interactive timeline of EMA’s main activities in 2020 plus visuals exploring topics in depth
• PDF version (below): downloadable, printable format with further figures and statistics on EMA's regulatory procedures and activities.

2020 annual report of the European Medicines Agency

Annexes - 2020 annual report of the European Medicines Agency

Annex 10 - 2020 annual report of the European Medicines Agency – CHMP opinions on initial evaluations and extensions of therapeutic indication

Annual activity report 2020

Reference Number: EMA/81758/2021

Final programming document 2020-2022

Adopted Reference Number: EMA/9529/2020

European Medicines Agency mid-year report 2020 (January-June 2020)

Reference Number: EMA/386447/2020

2019

EMA's annual report 2019 is available in two formats:

• Digital version with an interactive timeline of EMA's main activities in 2019 and key figures for the year;
• PDF version (below): downloadable, printable format with further figures and statistics on EMA's regulatory procedures and activities.

2019 annual report of the European Medicines Agency

Annexes - 2019 annual report of the European Medicines Agency

Annex 10 – 2019 annual report of the European Medicines Agency – CHMP opinions on initial evaluations and extensions of therapeutic indication

Annual activity report 2019

Reference Number: EMA/33568/2020

European Medicines Agency mid-year report 2019 from the Executive Director

Adopted Reference Number: EMA/619659/2019

Final programming document 2019-2021

Adopted Reference Number: EMA/912857/2019

2018

2018 annual report of the European Medicines Agency

Annexes - 2018 annual report of the European Medicines Agency

Annex 10 – 2018 annual report of the European Medicines Agency – CHMP opinions on initial evaluations and extensions of therapeutic indication

Reference Number: EMA/848994/2019 Corr.2

Annual activity report 2018

Reference Number: EMA/112688/2019

Multiannual work programme 2018-2020

Reference Number: EMA/73199/2018

Annual report 2018 on staff engaging in an occupational activity within two years of leaving the service (article 16 of the staff regulations)

Reference Number: EMA/131220/2019

2017

2017 annual report of the European Medicines Agency

Annexes - 2017 annual report of the European Medicines Agency

Annex 10 – 2017 annual report of the European Medicines Agency – CHMP opinions on initial evaluations and extensions of therapeutic indication

Reference Number: EMA/780996/2017

Annual activity report 2017

Adopted Reference Number: EMA/26967/2018

Work programme of the European Medicines Agency 2017

Reference Number: EMA/583016/2016 Rev. 1

2016

2016 annual report of the European Medicines Agency

Annexes - 2016 annual report of the European Medicines Agency

Annex 10 – 2016 annual report of the European Medicines Agency – CHMP opinions on initial evaluations and extensions of therapeutic indication

Reference Number: EMA/4995/2017

Annual activity report 2016

Adopted Reference Number: EMA/141860/2017 Summary:

European Medicines Agency annual activity report 2016

European Medicines Agency mid-year report 2016 from the Executive Director

Multiannual work programme to 2020

Reference Number: EMA/319713/2016

Work programme of the European Medicines Agency 2016

Reference Number: EMA/92499/2016 Rev.1 Summary:

European Medicines Agency work programme 2016

Annual report 2016 on staff engaging in an occupational activity within two years of leaving the service (article 16 of the staff regulations)

Reference Number: EMA/184994/2017

2015

Annual activity report 2015

Reference Number: EMA/140840/2016 Summary:

European Medicines Agency annual activity report 2015

2015 annual report of the European Medicines Agency

Reference Number: Corr

Annexes - 2015 annual report of the European Medicines Agency

Annex 10 - 2015 annual report of the European Medicines Agency - Positive and negative opinions; Withdrawn applications

Reference Number: EMA/156961/2016

European Medicines Agency mid-year report 2015 from the Executive Director

Reference Number: EMA/506004/2015 Summary:

Prepared by the Deputy Executive Director of the European Medicines Agency (EMA) for presentation to the Agency's Management Board on 2 October 2015.

Work programme of the European Medicines Agency 2015

Adopted Reference Number: EMA/773839/2014 Rev. 1

Annual reports for the period from 2012 to 2015 on staff engaging in an occupational activity within two years of leaving the service (article 16 of the staff regulations)

Reference Number: EMA/302717/2015

2014

Annual report of the European Medicines Agency 2014

Summary:

Annual report of the European Medicines Agency 2014

Annexes to the annual report of the European Medicines Agency 2014

Summary:

Annexes to the annual report of the European Medicines Agency 2014

Annual activity report 2014

Reference Number: EMA/92858/2015

Work programme of the European Medicines Agency 2014

Adopted Reference Number: EMA/695772/2013 Summary:

This work programme reflects the European Medicines Agency's (EMA) objectives and activities for

2014 that are aimed at reaching longer-term strategic goals.

2013

Annual report of the European Medicines Agency 2013

Annexes to the annual report of the European Medicines Agency 2013

Work programme of the European Medicines Agency 2013

Adopted Reference Number: EMA/MB/945561/2011

2012

Annual report of the European Medicines Agency 2012

Adopted

Annexes to the annual report of the European Medicines Agency 2012

Adopted

Work programme of the European Medicines Agency 2012

Adopted Reference Number: EMA/MB/554514/2011

2011

Annual report of the European Medicines Agency 2011

Adopted

Annual report 2011 (Annexes)

Adopted Reference Number: EMA/363033/2012

Work programme of the European Medicines Agency 2011

Adopted Reference Number: EMA/MB/482208/2010

2010

Summary of the annual report of the European Medicines Agency 2010

Adopted Reference Number: EMA/697914/2011

Annual report of the European Medicines Agency 2010

Adopted Reference Number: EMA/306870/2011

Annual report 2010 (Annexes)

Adopted Reference Number: EMA/457721/2011

Work programme for the European Medicines Agency 2010

Adopted Reference Number: EMA/MB/203131/2009

2009

Summary of the annual report of the European Medicines Agency 2009

Adopted Reference Number: EMA/499025/2010

Annual report of the European Medicines Agency 2009

Adopted Reference Number: EMA/MB/69923/2010

Annual report 2009 (Annexes)

Adopted

Work programme for the European Medicines Agency 2009

Adopted Reference Number: EMEA/87375/2009 Adopted

2008

Summary of the European Medicines Agency’s annual report for 2008

Adopted Reference Number: EMEA/362115/2009

Annual report of the European Medicines Agency 2008

Adopted Reference Number: EMEA/330566/2009

Work programme for the European Medicines Agency 2008

Adopted Reference Number: EMEA/MB/487174/2007 Adopted

Summary of the work programme for the European Medicines Agency 2008

Adopted Reference Number: EMEA/MB/556125/2007

2007

Summary of the European Medicines Agency’s annual report for 2007

Adopted Reference Number: EMEA/197729/2008/EN/FINAL

Annual report of the European Medicines Agency 2007

Adopted Reference Number: EMEA/MB/17464/2008

Summary of the work programme for the European Medicines Agency 2007

Adopted Reference Number: EMEA/MB/442095/2006

Work programme for the European Medicines Agency 2007

Adopted Reference Number: EMEA/MB/428793/2006/EN/FINAL

2006

Summary of the European Medicines Agency’s annual report for 2006

Adopted Reference Number: EMEA/88802/2007/EN/FINAL

Annual report of the European Medicines Agency 2006

Adopted Reference Number: EMEA/MB/24167/2007/EN/FINAL

Summary of the work programme for the European Medicines Agency 2006

Adopted Reference Number: EMEA/62913/2006

Work programme for the European Medicines Agency 2006

Adopted Reference Number: EMEA/MB/374230/2005

2005

Summary of the annual report of the European Medicines Agency 2005

Adopted Reference Number: EMEA/81246/2006

Annual report of the European Medicines Agency 2005

Adopted Reference Number: EMEA/MB/63019/2006

Work programme for the European Medicines Agency 2005

Adopted Reference Number: EMEA/MB/138351/2004/en/Final

1995-2004

Annual report of the European Medicines Agency 2004

Adopted Reference Number: EMEA/61492/2005/EN/Final

Work programme for the European Agency for the Evaluation of Medicinal Products 2004

Adopted Reference Number: EMEA/MB/58/03/en/FINAL

Annual report of the European Agency for Evaluation of Medicinal Products 2003

Adopted

Work programme for the European Agency for the Evaluation of Medicinal Products 2003

Adopted

Annual report of the European Agency for the Evaluation of Medicinal Products 2002

Adopted

Work programme for the European Agency for the Evaluation of Medicinal Products 2002

Adopted Reference Number: EMEA/MB/049/01-EN-Final

Annual report of the European Agency for Evaluation of Medicinal Products 2001

Adopted

Work programme for the European Agency for the Evaluation of Medicinal Products 2001-2002

Adopted

Annual report of the European Agency for Evaluation of Medicinal Products 2000

Adopted

Work programme for the European Agency for the Evaluation of Medicinal Products 2000-2001

Adopted

Annual report of the European Agency for Evaluation of Medicinal Products 1999

Adopted

Work programme for the European Agency for the Evaluation of Medicinal Products 1999-2000

Adopted

Annual report of the European Agency for Evaluation of Medicinal Products 1998

Adopted

Work programme for the European Agency for the Evaluation of Medicinal Products 1998-1999

Adopted

Annual report of the European Agency for Evaluation of Medicinal Products 1997

Adopted

Work programme for the European Agency for the Evaluation of Medicinal Products 1997-1998

Adopted Reference Number: EMEA/MB/002/97.final

Annual report of the European Agency for Evaluation of Medicinal Products 1996

Adopted

Annual report of the European Agency for Evaluation of Medicinal Products 1995

Adopted

Page update history

An update log is available to show the date and summary of changes to this webpage. It does not include updates to linked documents or minor edits like typos or broken link fixes.

The tracking of updates begins in June 2026.

See update history

11 June 2026

'2025 annual report' published.